Literature DB >> 8980638

Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.

B McCormack1, G Gregoriadis.   

Abstract

Inclusion complexes of 14C-labelled hydroxypropyl-beta-cyclodextrin (HP beta-CD) with tritiated dehydroepiandrosterone (DHEA), retinol (RET) and dexamethasone (DEX) were entrapped in the aqueous phase of liposomes composed of distearoyl phosphatidylcholine. Incubation of liposome-entrapped complexes in the presence of rat blood plasma at 37 degrees C resulted in complex dissociation and drug leakage in the media at a rate which was minimal for DEX/HP beta-CD (11%), modest for RET/HP beta-CD (23%) and considerable for DHEA/HP beta-CD (56%; 60 min). In contrast, the HP beta-CD moiety of the complexes was retained by liposomes quantitatively. Free complexes injected intravenously into rats were cleared rapidly from the circulation with most (up to 94%) of the HP beta-CD moiety recovered in 24 urine together with lesser and variable amounts of drug (up to 46% of the dose) in a pattern (DHEA < RET < DEX) that was consistent with the extent of drug association with HP beta-CD in the presence of plasma. A significant proportion of the drugs (up to 25% of the dose)(but very little HP beta-CD) was removed by the liver where drugs were catabolised rapidly, probably following complex dissociation and transport to the tissue via plasma proteins. Injection of entrapped complexes revealed that liposomes alter their pharmacokinetics with only 6-13% of HP beta-CD and a moderate proportion of drugs (up to 26% of the dose) recovered in the urine. Much of the HP beta-CD moiety of the liposomal complexes was recovered in the liver (up to 83%) and spleen (up to 13% of the dose) by 30 min after injection, together with a variable proportion of drugs in a pattern (DHEA < RET < DEX) which reflected that of complex dissociation in vitro. Longer term experiments where animals injected with liposome-entrapped complexes were killed at time intervals (up to 24 days), revealed that HP beta-CD is eliminated from the tissues, albeit at a very slow rate. Moreover, the metabolism of individual drugs in the tissues following vesicle disintegration, appeared to depend on the rate of complex dissociation with DEX, for instance, reaching values of 4-6% (liver) only after 14 days. It is concluded that administration of drug/cyclodextrin inclusion complexes via liposomes could serve as a means to control the action of a wide range of therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980638     DOI: 10.1016/s0304-4165(96)00096-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Glyco-poly-l-lysine is better than liposomal delivery of exogenous genes to rat of liver.

Authors:  Chang-Qing Yang; Ji-Yao Wang; Bo-Ming He; Jian-Jun Liu; Jin-Sheng Guo
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  The use of phospholipid nanoparticles for increasing Semax resistance in various proteolytic biological media.

Authors:  K V Shevchenko; A P Khrapko; V I Schwets; N F Myasoyedov
Journal:  Dokl Biol Sci       Date:  2009 Nov-Dec

Review 3.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

4.  Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model.

Authors:  H Agashe; P Lagisetty; K Sahoo; D Bourne; B Grady; V Awasthi
Journal:  J Nanopart Res       Date:  2011-06-01       Impact factor: 2.253

5.  Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.

Authors:  Vijay Joguparthi; Bradley D Anderson
Journal:  Pharm Res       Date:  2008-07-19       Impact factor: 4.200

6.  In Vitro and Ex Vivo Evaluation of Tablets Containing Piroxicam-Cyclodextrin Complexes for Buccal Delivery.

Authors:  Eleni Kontogiannidou; Martina Ferrari; Asteria-Danai Deligianni; Nikolaos Bouropoulos; Dimitrios A Andreadis; Milena Sorrenti; Laura Catenacci; Kazem Nazari; Muhammad Sohail Arshad; Ming-Wei Chang; Zeeshan Ahmad; Dimitrios G Fatouros
Journal:  Pharmaceutics       Date:  2019-08-08       Impact factor: 6.321

Review 7.  A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs.

Authors:  Bina Gidwani; Amber Vyas
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.